Report No. 6/2026 Obtaining Information on the Issuance of a GMP Certificate for Bioceltix S.A.

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A. (the “Company”, the “Issuer”), with reference to current report ESPI No. 51/2025 dated 23 December 2025 regarding receipt of the final report from the Chief Pharmaceutical Inspector (Główny Inspektor Farmaceutyczny, “GIF”) confirming the Company’s compliance with Good Manufacturing Practice (“GMP”), hereby announces that on 17 February 2026 […]